Fatty liver other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
m Template |
No edit summary |
||
| Line 8: | Line 8: | ||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
The FIB-4 has some value in screening<ref name="pmid35947698">{{cite journal| author=Kim RG, Deng J, Reaso JN, Grenert JP, Khalili M| title=Noninvasive Fibrosis Screening in Fatty Liver Disease Among Vulnerable Populations: Impact of Diabetes and Obesity on FIB-4 Score Accuracy. | journal=Diabetes Care | year= 2022 | volume= | issue= | pages= | pmid=35947698 | doi=10.2337/dc22-0556 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=35947698 }} </ref>. | |||
==References== | ==References== | ||
| Line 16: | Line 17: | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Latest revision as of 01:37, 29 August 2022
|
Fatty Liver Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fatty liver other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Fatty liver other diagnostic studies |
|
Risk calculators and risk factors for Fatty liver other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Other Diagnostic Studies
The FIB-4 has some value in screening[1].
References
- ↑ Kim RG, Deng J, Reaso JN, Grenert JP, Khalili M (2022). "Noninvasive Fibrosis Screening in Fatty Liver Disease Among Vulnerable Populations: Impact of Diabetes and Obesity on FIB-4 Score Accuracy". Diabetes Care. doi:10.2337/dc22-0556. PMID 35947698 Check
|pmid=value (help).